HUMA – humacyte, inc. (US:NASDAQ)
Stock Stats
News
Humacyte (HUMA) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $25.00 price target on the stock.
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair [Yahoo! Finance]
Humacyte Submits Marketing Authorization Application for Symvess® in Israel for Vascular Trauma Repair
Humacyte, Inc. (HUMA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
Humacyte, Inc. (HUMA) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Form SCHEDULE 13D/A Humacyte, Inc. Filed by: Fresenius Medical Care AG
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.